Skip to main content
Shanghai Kindly Enterprise Development Group Co.,Ltd. logo

Shanghai Kindly Enterprise Development Group Co.,Ltd. — Investor Relations & Filings

Ticker · 603987 ISIN · CNE100003076 LEI · 3003003G07QZESUB1P38 Shanghai Stock Exchange Manufacturing
Filings indexed 1,380 across all filing types
Latest filing 2022-06-29 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 603987

About Shanghai Kindly Enterprise Development Group Co.,Ltd.

https://www.kindly-group.com/

Shanghai Kindly Enterprise Development Group Co., Ltd. specializes in the research, development, and manufacturing of medical puncture instruments and related consumables. The company's product portfolio includes a wide range of hypodermic needles, syringes, infusion sets, and blood collection devices. KDL also produces specialized medical components such as insulin needles, dental needles, and aesthetic medical instruments. With a focus on precision engineering and high-quality standards, the group serves a global market, providing essential medical supplies to healthcare facilities and distributors. The company maintains a comprehensive production chain from raw materials to finished products, ensuring consistency and safety in clinical applications.

Recent filings

Filing Released Lang Actions
光大证券股份有限公司关于上海康德莱企业发展集团股份有限公司本次交易产业政策和交易类型之独立财务顾问核查意见
Audit Report / Information Classification · 95% confidence The document is a formal opinion report from an independent financial advisor (光大证券股份有限公司) regarding a major asset restructuring transaction involving 上海康德莱企业发展集团股份有限公司. It discusses the nature of the transaction, industry classification, regulatory compliance, and confirms that the transaction does not involve issuance of shares or constitute a reorganization listing. The document references regulatory guidelines from the China Securities Regulatory Commission and Shanghai Stock Exchange. It is a specialized advisory and verification opinion related to a major asset restructuring, not a full annual or interim financial report, earnings release, or other types of filings. It is not a mere announcement or certification but a detailed independent financial advisor's opinion on the transaction type and policy compliance. This fits the category of Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to transactions and regulatory compliance, excluding full annual reports. FY 2024
2022-06-29 Chinese
光大证券股份有限公司关于本次重组相关主体不存在《上市公司监管指引第 7 号-上市公司重大资产重组相关股票异常交易监管》第十三条规定情形的核查意见
Regulatory Filings Classification · 95% confidence The document is a formal opinion from an independent financial advisor (光大证券股份有限公司) regarding a major asset restructuring (重大资产重组) of a listed company (上海康德莱企业发展集团股份有限公司). It specifically states that the involved parties do not fall under prohibited conditions related to insider trading or regulatory sanctions as per the relevant regulatory guidelines (上市公司监管指引第7号). The document is a verification or certification opinion related to compliance with regulatory requirements for a major asset restructuring, not the restructuring announcement itself or a full financial report. The document length is short (1146 characters), and it is a formal statement or certification rather than a full report or announcement of results. This fits best under Regulatory Filings (RNS), which covers compliance documents and attestation letters that do not contain substantive financial data or full reports.
2022-06-29 Chinese
德恒上海律师事务所关于关于上海康德莱企业发展股份有限公司内幕信息知情人登记制度的制定和执行情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a legal opinion issued by a law firm (德恒上海律师事务所) regarding the establishment and execution of an insider information registration system for Shanghai Kangdelai Enterprise Development Group Co., Ltd. It references compliance with securities laws and regulations, and is related to a major asset restructuring project. The document is a specialized legal verification or audit opinion rather than a full annual report, earnings release, or management report. It does not contain financial statements or detailed financial analysis but rather a legal compliance check and opinion. This fits the category of an Audit Report / Information (AR), which includes standalone audit reports and results of regulatory or internal checks excluding full annual reports. The document length is 2704 characters, which is consistent with a standalone legal audit opinion rather than a full report or announcement. Therefore, the appropriate classification is AR with high confidence. FY 2022
2022-06-29 Chinese
上海康德莱医疗器械股份有限公司审计报告及财务报表二〇二一年度
Regulatory Filings
2022-06-29 Chinese
上海康德莱企业发展集团股份有限公司第四届监事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 13th meeting of the 4th Supervisory Board of Shanghai Kangdelai Enterprise Development Group Co., Ltd. It details the meeting attendance, the agenda items discussed, and the voting results on various proposals related to a major asset restructuring. The document does not contain financial statements or detailed financial data but rather reports on board-level decisions and approvals. It is not an annual report, audit report, or earnings release. It is also not a call transcript or investor presentation. The content focuses on management/board decisions and approvals, specifically from the supervisory board, which aligns with Board/Management Information filings. The document length is 2829 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report. Therefore, the appropriate classification is Board/Management Information (MANG).
2022-06-29 Chinese
上海康德莱企业发展集团股份有限公司审阅报告及备考合并财务报表二〇二一年度
Regulatory Filings
2022-06-29 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.